141 related articles for article (PubMed ID: 38010402)
41. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
[TBL] [Abstract][Full Text] [Related]
42. Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.
Jung KY; Kim SM; Yoo WS; Kim BW; Lee YS; Kim KW; Lee KE; Jeong JJ; Nam KH; Lee SH; Hah JH; Chung WY; Yi KH; Park DJ; Youn YK; Sung MW; Cho BY; Park CS; Park YJ; Chang HS
Clin Endocrinol (Oxf); 2016 Apr; 84(4):587-97. PubMed ID: 26175307
[TBL] [Abstract][Full Text] [Related]
43. Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old.
Yang B; Niu G; Li X; Ma F; Ma Y; Hu S
Front Endocrinol (Lausanne); 2022; 13():1015319. PubMed ID: 36339396
[TBL] [Abstract][Full Text] [Related]
44. National Trends in the Surgical Treatment of Non-advanced Medullary Thyroid Cancer (MTC): An Evaluation of Adherence with the 2009 American Thyroid Association Guidelines.
Chang EHE; Lutfi W; Feinglass J; Reiher AE; Moo-Young T; Bhayani MK
World J Surg; 2016 Dec; 40(12):2930-2940. PubMed ID: 27447700
[TBL] [Abstract][Full Text] [Related]
45. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness.
Voss RK; Feng L; Lee JE; Perrier ND; Graham PH; Hyde SM; Nieves-Munoz F; Cabanillas ME; Waguespack SG; Cote GJ; Gagel RF; Grubbs EG
J Clin Endocrinol Metab; 2017 Aug; 102(8):2807-2813. PubMed ID: 28609830
[TBL] [Abstract][Full Text] [Related]
46. High frequency ultrasound features and pathological characteristics of medullary thyroid carcinoma.
Wang H; Liu M; Yang J; Song Y
Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2269-2271. PubMed ID: 28167464
[TBL] [Abstract][Full Text] [Related]
47. [Expression and clinical significance of Ki67 and calcitonin in medullary thyroid carcinoma].
Feng J; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Dec; 28(24):1921-4. PubMed ID: 25895305
[TBL] [Abstract][Full Text] [Related]
48. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
[No Abstract] [Full Text] [Related]
49. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
Torresan F; Mian C; Cavedon E; Iacobone M
Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267
[TBL] [Abstract][Full Text] [Related]
50. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
[TBL] [Abstract][Full Text] [Related]
51. Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma.
Liu MJ; Liu ZF; Hou YY; Men YM; Zhang YX; Gao LY; Liu H
Oncotarget; 2017 Apr; 8(16):27520-27528. PubMed ID: 28460476
[TBL] [Abstract][Full Text] [Related]
52. Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience.
Jeong SI; Kim W; Yu HW; Choi JY; Ahn CH; Moon JH; Choi SI; Cha W; Jeong WJ; Park SY; Na HY
Endocr Pathol; 2023 Sep; 34(3):287-297. PubMed ID: 37515661
[TBL] [Abstract][Full Text] [Related]
53. An Overview of Medullary Thyroid Cancer Cases Treated at Kuwait Cancer Control Center.
Shete J; AlSaleh K; Safwat R; Bedair A; ElSherify M; Hussein A; Nazeeh M; Mohanty A
Gulf J Oncolog; 2020 Sep; 1(34):39-47. PubMed ID: 33431361
[TBL] [Abstract][Full Text] [Related]
54. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
[TBL] [Abstract][Full Text] [Related]
55. The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma.
Zhu J; Li X; Wei X; Yang X; Zhao J; Zhang S; Guo Z
Cancer Med; 2019 Jul; 8(7):3389-3400. PubMed ID: 31070290
[TBL] [Abstract][Full Text] [Related]
56. PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.
Momin S; Chute D; Burkey B; Scharpf J
Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
[TBL] [Abstract][Full Text] [Related]
57. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
Torresan F; Cavedon E; Mian C; Iacobone M
World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
[TBL] [Abstract][Full Text] [Related]
58. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
Filimon S; Payne RJ; Black MJ; Hier MP; Mlynarek AM; Forest VI; Tamilia M
Endocr Pract; 2018 May; 24(5):460-467. PubMed ID: 29847167
[TBL] [Abstract][Full Text] [Related]
59. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
60. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
